Emfilermin

CAT: 0931-T82475-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0931-T82475-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

CAS Number

159075-60-2

Target

Interleukin

Related Pathways

Immunology/Inflammation

Bioactivity

Emfilermin, a recombinant human leukemia inhibitory factor (LIF), is utilized in the research of chemotherapy-induced peripheral neuropathy [1].

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Alternative Products

Catalog	Name
GTR19034677-01	Emfilermin
PX-TA1947-01	Falbikitug Biosimilar - Anti-Emfilermin mAb - Research Grade
322379-01	LIF (Leukemia Inhibitory Factor, Differentiation-stimulating Factor, D Factor, Melanoma-derived LPL Inhibitor, MLPLI, Emfilermin, HILDA)
322382	LIF (Leukemia Inhibitory Factor, LIF, Differentiation-stimulating Factor, D Factor, Melanoma-derived LPL Inhibitor, MLPLI, Emfilermin, HILDA) discontinued
MBS650734-01	LIF, Recombinant, Human (Leukemia Inhibitory Factor, Differentiation-stimulating Factor, D Factor, Melanoma-derived LPL Inhibitor, MLPLI, Emfilermin, HILDA)
360691-01	LIF (Leukemia Inhibitory Factor, Differentiation- Stimulating Factor, D Factor, Melanoma-derived LPL Inhibitor, MLPLI, Emfilermin, HILDA) discontinued
143424-01	Leukemia Inhibitory Factor, Recombinant, Human (LIF, Differentiation-stimulating Factor, D Factor, Melanoma-derived LPL Inhibitor, MLPLI, INN=Emfilermin, HILDA)
223902-01	LIF (Leukemia Inhibitory Factor, LIF, Differentiation-stimulating Factor, D Factor, Melanoma-derived LPL Inhibitor, MLPLI, INN=Emfilermin, LIF, HILDA)
363964	LIF (Leukemia Inhibitory Factor, CDF, D-FACTOR, HILDA, MLPLI, Cholinergic Differentiation Factor, Differentiation-Stimulating Factor, Melanoma-Derived LPL Inhibitor, Emfilermin)
500209	LIF, Recombinant, Human (LIF, Differentiation-Stimulating Factor, D Factor, Melanoma-Derived LPL inhibitor, MLPLI, INN=Emfilermin, HILDA, Leukemia Inhibitory Factor) discontinued